EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

W. R. Berkley Corporation (W1RB34) fair value: what the stock is really worth

As of Sep 30, 2026: fair value of W. R. Berkley Corporation BRL 18.48, price BRL 33.85, upside -45.4%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Financial Services · BR · ISIN US0844231029

WR Broad data Sep 29, 2026

W. R. Berkley Corporation

W1RB34 · SA

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value R$18.48 · Strongly overvalued (−45.4%)
✓Quality 67/100
✓Healthy Growth (revenue 3y +9.6 %/yr)
✓Solidly profitable · 12.6% net margin (TTM)
✓Low debt · generates free cash flow
✓1.1% dividend yield · Well covered
!Moderate moat 59/100

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

R$43.93 R$26.52 Fair Value R$18.48 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.

How to read this chart

60‑month range R$26.52 – R$43.93 · fair‑value band R$14.22 – R$28.20 · the R$33.85 price screens above the R$18.48 fair value. Dashed = 300-day average. As of Sep 29, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide. The company operates through Insurance and Reinsurance & Monoline Excess segments. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines.

Show more

W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide. The company operates through Insurance and Reinsurance & Monoline Excess segments. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines. This segment also provides accident and health insurance and reinsurance products; insurance for commercial risks; casualty and specialty environmental products; insurance coverages for fine arts and jewelry exposures; excess liability and inland marine coverage for small to medium-sized insureds; and commercial general liability, umbrella, professional liability, directors and officers, commercial property, and surety products, as well as products for technology, and life sciences and travel industries. In addition, it offers cyber risk solutions; crime and fidelity insurance products; medical professional coverages; workers' compensation insurance products; management liability and general insurance products; personal lines insurance solutions, including home, condo/co-op, auto, fine arts and collectibles, liability, collector vehicle, and recreational marine; law enforcement, public officials and educator's legal, and employment practices liability, as well as incidental medical, property, and crime insurance products; at-risk and alternative risk insurance program management services; professional liability; energy and marine risks; and insurance products to the Lloyd's marketplace. The Reinsurance & Monoline Excess segment provides treaty and facultative reinsurance solutions; property and casualty reinsurance products; facultative reinsurance products include automatic, semi-automatic, and individual risk assumed reinsurance; and turnkey products, such as cyber, employment practices liability insurance, liquor liability insurance and violent events. The company was founded in 1967 and is headquartered in Greenwich, Connecticut.

Stock analysis

W. R. Berkley Corporation (W1RB34) currently trades at R$33.85, while our model-based Fair Value estimate is R$18.48, 45.4% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Economic Profit group reads highest at a median of R$20.97 per share, and 0 of the 6 models we run sit above the R$33.85 price.

Bear case: the Asset-Based group reads lowest at R$9.12, and 6 of the 6 models stay below the price. Evidence for this calculation is high.

Scenario range: R$14.22 (bear) to R$28.20 (bull), the price of R$33.85 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 67/100 (solid quality), in the Financial Services sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

W. R. Berkley Corporation reported revenue of $14.7B in FY2025 versus $9.5B in FY2021, a compound +11.6%/yr. Reported net income was $1.8B in FY2025, compounding +14.9%/yr from FY2021.

Key figures

Market cap R$137B (≈ $26.3B) · P/E ratio 13.8 · P/S ratio 1.67 · EPS (TTM) R$2.45 · Dividend yield 1.1% · Net margin 12.1% · Return on equity 20.2% · Return on assets (EBIT) 5.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 19% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −22% fair-value upside, at −45%, W1RB34 screens richer than that median.

Fair Value models

Bear R$14.22 Fair Value R$18.48 Bull R$28.20
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (R$1.58 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income R$15.98 R$20.97 R$34.56 71
DDM Multi-Stage R$9.02 R$15.81 R$19.68 64
Gordon GGM R$9.02 R$18.75 R$29.75 63
All 6 models by family
Dividend Discount
Gordon GGM R$9.02 R$18.75 R$29.75 63
DDM Multi-Stage R$9.02 R$15.81 R$19.68 64
Multiples
P/E Multiple R$24.34 R$32.45 R$40.56 63
P/B Multiple R$14.29 R$19.05 R$23.81 55
Asset-Based
NCAV (Graham) R$6.80 R$9.12 R$13.61 54
Economic Profit
Residual Income R$15.98 R$20.97 R$34.56 71

Open the full fair value analysis →

Notify me when W1RB34 reaches fair value

Put W1RB34 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 67/100

Of which business quality 66 · Market factors (momentum, volatility) 47

Profitability 44
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 95
Earnings quality: real cash, not paper profit
Fin. Strength 57
Balance sheet, leverage, solvency risk
Investment 63
Disciplined investing over empire-building
Low Volatility 94
Calm price path (market factor)
Momentum 35
Price trend over the last 3–12 months (market factor)
52W Momentum 15
Distance to the 52-week high (market factor)
Net Issuance 94
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+7.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+14.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+12.9%
Dividend (yield on the price)1.1%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 17%

W1RB34 screens overvalued: fair value 45% below the price. Compare with Chubb Limited →

Compare W. R. Berkley Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Insurance - Property & Casualty stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Chubb Limited CB $331.37 $235.99 −29%
The Progressive Corporation PGR $209.47 $160.75 −23%
The Travelers Companies, Inc TRV $356.51 $279.78 −22%
The Allstate Corporation ALL $224.41 $290.52 +29%
The People's Insurance Company 601319 ¥7.98 ¥9.02 +13%
Fairfax Financial Holdings FFH C$2,219 C$3,257 +47%
Intact Financial Corporation IFC C$250.54 C$167.88 −33%
Cincinnati Financial Corporation CINF $161.92 $143.72 −11%
QBE Insurance Group QBE A$23.81 A$13.42 −44%
Unipol Assicurazioni S.p.A UNI €25.79 €16.11 −38%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

W. R. Berkley Corporation · Fair Value
R$18.48 −45%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "W. R. Berkley Corporation Fair Value". https://www.fairvalue-calculator.com/stock/W1RB34

Frequently asked questions

Is W. R. Berkley Corporation (W1RB34) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of R$18.48 versus a price of R$33.85, about −45% upside (overvalued).
What is the fair value of W1RB34?
Our model-based fair value for W. R. Berkley Corporation is R$18.48 (as of Sep 29, 2026), built from audited fundamentals. The current price: R$33.85.
What is the quality score of W1RB34?
W. R. Berkley Corporation has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for W. R. Berkley Corporation (W1RB34)?
Our model-based price target is the fair value of R$18.48 (as of Sep 29, 2026) from 6 valuation models. Cautious scenario R$14.22, optimistic scenario R$28.20. It is a calculation from audited fundamentals, not an analyst target.
What is the W. R. Berkley Corporation stock forecast for 2026?
Our models put fair value at R$18.48, about −45% upside versus a price of R$33.85 (overvalued). Cautious scenario R$14.22, optimistic scenario R$28.20. The calculation is refreshed regularly with new filings.
What is the revenue of W. R. Berkley Corporation (W1RB34)?
W. R. Berkley Corporation reported trailing-twelve-month revenue of about $14.9B (latest available figure, as of Sep 29, 2026).
Does W. R. Berkley Corporation pay a dividend?
W. R. Berkley Corporation currently shows a dividend yield of about 1.06% relative to its recent price (as of Sep 29, 2026).
What is the intrinsic value of W. R. Berkley Corporation (W1RB34)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For W. R. Berkley Corporation it is R$18.48 per share (as of Sep 29, 2026), against a price of R$33.85. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is W. R. Berkley Corporation stock overvalued or undervalued in 2026?
As of Sep 29, 2026, W1RB34 trades above its calculated fair value: price R$33.85, fair value R$18.48, a gap of about −45% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of W1RB34?
No. The price is what the market pays today (R$33.85); the fair value is what the company's own numbers justify (R$18.48). For W. R. Berkley Corporation the two are R$15.37 per share apart. That gap is exactly why we show both numbers side by side.
How much is W. R. Berkley Corporation worth?
The market values W. R. Berkley Corporation at about R$137B (market capitalisation, as of Sep 29, 2026). Per share that is R$33.85; our models calculate a fair value of R$18.48 per share.
What do the bullish and bearish scenarios say about W1RB34?
Our models span a range for W. R. Berkley Corporation: cautious scenario R$14.22, base R$18.48, optimistic R$28.20 per share (as of Sep 29, 2026, price R$33.85). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is W1RB34 from its 52-week high?
W. R. Berkley Corporation trades at R$33.85, about 19% below its 52-week high of R$42.02 and 3% above the low of R$32.86 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of R$18.48 is for.
Which stocks are comparable to W. R. Berkley Corporation?
From the same area (Financial Services) we also value Chubb Limited, The Progressive Corporation, The Travelers Companies, Inc, The Allstate Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is W. R. Berkley Corporation stock attractive at the current price?
The data as of Sep 29, 2026: price R$33.85, calculated fair value R$18.48 (−45%), Quality Score 67/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of W1RB34 calculated?
We run W. R. Berkley Corporation through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of R$18.48, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. W. R. Berkley Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of W. R. Berkley Corporation (W1RB34)?
The closing price on Sep 30, 2026 was R$33.85. Our model-based fair value is R$18.48, about −45% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with W. R. Berkley Corporation right now?
The price sits above even our optimistic bull case (R$28.20). The favourable scenario is already priced in. Solid but not exceptional quality (67/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (R$14.22 to R$28.20) leaves room in how you read the outcome. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of W. R. Berkley Corporation

How large is the market capitalisation of W. R. Berkley Corporation (W1RB34)?
The market capitalisation of W. R. Berkley Corporation is R$137B (≈ $26.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of W. R. Berkley Corporation (W1RB34)?
The price-to-earnings ratio of W. R. Berkley Corporation is 13.8. Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What is the P/S ratio of W. R. Berkley Corporation (W1RB34)?
The price-to-sales ratio of W. R. Berkley Corporation is 1.67 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of W. R. Berkley Corporation (W1RB34)?
Earnings per share at W. R. Berkley Corporation are R$2.45 (price ÷ EPS = P/E 13.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of W. R. Berkley Corporation (W1RB34)?
The dividend yield of W. R. Berkley Corporation is 1.1% (payout 14.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of W. R. Berkley Corporation (W1RB34)?
The net margin of W. R. Berkley Corporation is 12.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of W. R. Berkley Corporation (W1RB34)?
The return on equity (ROE) of W. R. Berkley Corporation is 20.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of W. R. Berkley Corporation (W1RB34)?
On an EBIT basis the return on assets of W. R. Berkley Corporation is 5.4% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of W. R. Berkley Corporation (W1RB34)?
The operating margin of W. R. Berkley Corporation is 17.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at W. R. Berkley Corporation (W1RB34)?
Revenue at W. R. Berkley Corporation is growing +4.0% versus a year earlier (3y avg +9.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at W. R. Berkley Corporation (W1RB34)?
Earnings per share at W. R. Berkley Corporation are growing +26.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does W. R. Berkley Corporation (W1RB34) generate?
The free cash flow of W. R. Berkley Corporation is $3.4B (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does W. R. Berkley Corporation (W1RB34) carry?
The net debt of W. R. Berkley Corporation is $300M (fiscal year 2025, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.